Endpoint | Variable | HR | 95% CI | P-value |
---|---|---|---|---|
Overall survival | MPTD | 4.300 | 2.233-8.279 | <0.001 |
Failure-free survival | MPTD | 3.968 | 2.402-6.559 | <0.001 |
N stage | 1.802 | 1.111-2.923 | 0.017 | |
Distant metastasis-free survival | MPTD | 5.153 | 2.729-9.729 | <0.001 |
N stage | 2.329 | 1.334-4.064 | 0.003 | |
Local relapse-free survival | MPTD | 3.277 | 1.355-7.927 | 0.008 |